Sign inJoin waitlistJoin the waitlist

Prateek Gulhati

Associate Director for Clinical Research and Director, GI Oncology, Rutgers Cancer Institute · Rutgers Health

Credentials: · · · · · ·

History

Rutgers Health
Present
Rutgers Health
Present

University of Texas M D Anderson Cancer Center
2015–2017
Internal Medicine
Mount Sinai Hospital
2013–2015
The University of Texas
University of Texas Medical Branch at Galveston School of Medicine
2009–2013
Physiology (Honors), University of British Columbia, 2002
2005–2009

Research

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways
Cancer Research · 2011 · First of 11 authors · 481 citations
mTOR inhibitors in cancer therapy
Review · Cancer Letters · 2012 · 236 citations
Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer
Journal of the American College of Surgeons · 2010 · 214 citations

Mark Evers
12 papers
Eun Lee
5 papers
Huamin Wang
5 papers
Rachna Shroff
5 papers
Michael Overman
4 papers
Anirban Maitra
3 papers
GV
Gauri Varadhachary
3 papers
Hung Doan
3 papers
Jashodeep Datta
3 papers
John Marshall
3 papers
Kanika Bowen-Jallow
3 papers · 3 as a resident
Milind Javle
3 papers

Clinical trials

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy
Principal investigator · Withdrawn · Phase 2
Rutgers, The State University of New Jersey
2022–2024